The nasal route opens up an avenue of possibilities for a drug to reach the brain. Clonazepam is highly metabolized with a poor uptake by the blood brain barrier via the peripheral circulation\[[@CIT1]\]. Hence, the objective of this investigation was to prepare brain-targeted gelatin-chitosan mucoadhesive microspheres to obtain rapid onset of action.

MATERIALS AND METHODS {#sec1-1}
=====================

Clonazepam, USP was a gift sample from IPCA Laboratories, Mumbai; Chitosan was provided by Healer\'s Neutraceuticals, Chennai. All other chemicals and solvents were of analytical reagent grade and were locally procured. The emulsion cross-linking method was used\[[@CIT2]\]. Gelatin-chitosan mix along with clonazepam was added under constant stirring in paraffin oil. PEG 400 was the co-solvent employed. Glutaraldehyde-saturated toluene was used as the cross linking agent. Surfactant used was sodium lauryl sulfate (SLS, 0.01% v/v). After the microspheres were formed they were washed with isopropyl alcohol and air dried. The formulations prepared were showed in [Table 1](#T0001){ref-type="table"}. Percent yield was determined by difference in weight before and after the preparation of microspheres\[[@CIT2]\].

###### 

FORMULATION TABLE

  Batch No.   Chitosan: gelatin ratio   Drug amount (mg)   Volume of SLS (0.01% v/v) (ml)   Aqueous to oily ratio
  ----------- ------------------------- ------------------ -------------------------------- -----------------------
  LM 1        2:5                       50                 1                                1:20
  LM 2        2:5                       50                 0.75                             1:20
  LM 3        2:5                       50                 0.5                              1:20
  LM 4        3:10                      46.42              1                                1:20
  LM 5        3:10                      46.42              0.75                             1:20
  LM 6        3:10                      46.42              0.5                              1:20
  LM 7        2:10                      45.85              1                                1:20
  LM 8        2:10                      45.85              0.75                             1:20
  LM 9        2:10                      45.85              0.5                              1:20

Particle size analysis was done microscopically using an optical microscope (Metzer OPTIK), under 450X (10X eye piece and 45X objective)\[[@CIT2]\]. One hundred particles were counted. Entrapment efficiency was calculated by soaking the microspheres in methanol and determining the content spectrophotometrically (V-550, Jasco, Japan)\[[@CIT3]\]. Evaluation of mucoadhesion was carried out using rat intestinal tissue. The amount of microspheres attaching to the tissue was determined by the weight difference\[[@CIT4]\]. For *in vitro* release, the paddle method (TDT-08L, Electrolab, India) of dissolution was employed over a period of 2 h. Release was compared against plain drug dissolution\[[@CIT5]\]. *Ex vivo* release was determined using sheep nasal mucosa\[[@CIT6]\]. Here too, the comparison was against plain drug solution. The set up used for this purpose is shown in [fig. 1](#F0001){ref-type="fig"}. Further, for *in vivo* studies, a comparison was made between the formulation administered via the nasal route and clonazepam solution administered intravenously to rats\[[@CIT7]\]. Plasma and CSF were withdrawn at set time points. Drug content was analyzed in both the fluids and concentration-time profiles were plotted and pharmacokinetics parameters calculated. Using these values, drug targeting index and drug targeting efficiency were found out.

![Modified dissolution apparatus\
Dissolution apparatus for evaluation of *ex vivo* permeation of clonazepam-loaded microspheres\[[@CIT6]\].](IJPhS-71-715-g001){#F0001}

RESULTS AND DISCUSSION {#sec1-2}
======================

Percent yield ranged from 65.1 to 75.4%. The average particle size ranged from 61-75.2 μm. Particle size distribution of LM 1 is shown in [fig. 2](#F0002){ref-type="fig"}. Volume of surfactant used played an important role in reducing the particle size. Entrapment values ranged from 38.9-54.23%. The use of PEG 400 enhanced entrapment. The mucoadhesion range was found to be 82.62-89.56%. Mucoadhesion value dropped with reducing the amount of chitosan. Results of the above parametes are tabulated in [Table 2](#T0002){ref-type="table"}. The *in vitro* release obtained was 99.78% as seen in [fig. 3](#F0003){ref-type="fig"}. The *ex vivo* release achieved was 98.17 % as denoted in [fig. 4](#F0004){ref-type="fig"}. Chitosan crucially contributed towards a good release\[[@CIT6]\]. *In vivo* studies indicated higher concentration of clonazepam in CSF when administered intranasally as represented in figs. [5](#F0005){ref-type="fig"} and [6](#F0006){ref-type="fig"}. Drug targeting index was 2.12 and drug targeting efficiency was 51.71%. Here again chitosan contributed towards a good release\[[@CIT6]\]. A drug targeting index value more than one indicates direct transport to the brain. Clonazepam is a low molecular weight (315.7) lipophilic moiety, thus indicating towards the possibility of utilizing the transcellular pathway to reach the brain\[[@CIT7]\]. Hence, a formulation was developed for better drug distribution into the brain, increasing the therapeutic index, reducing side effects with decreased dose for clonazepam.

![Size distribution for LM 1.](IJPhS-71-715-g002){#F0002}

![*In vitro* release studies of pure drug and the clonazepamloaded microspheres](IJPhS-71-715-g003){#F0003}

![*Ex vivo* release studies of pure drug and the clonazepamloaded microspheres.\
*Ex vivo* release studies were performed using () pure drug and colazepam-loaded microspheres () LM1, () LM2, (s) LM3, () LM4, () LM5, () LM6, () LM7, () LM8 and () LM9.](IJPhS-71-715-g004){#F0004}

![Plasma concentration-time profile of clonazpam after intravenous and intranasal administration\
Plasma concentration-time profile of clonazpam after () intravenous and () intranasal administration of a 0.16-0.2 mg/kg dose in rats](IJPhS-71-715-g005){#F0005}

![CSF concentration-time profile of clonazepam after intravenous and intranasal administration\
Cerebro spinal fluid concentration-time profile of clonazepam after () intravenous and () intranasal administration of a 0.16-0.2 mg/kg dose in rats](IJPhS-71-715-g006){#F0006}

###### 

CHARACTRIZATIONS OF CLONAZEPAM LOADED MICROSPHERES

  Batch no.   Percent yield   Average particle size (μm)[\*](#T000F1){ref-type="table-fn"}   Average entrapment efficiency (%)[\#](#T000F2){ref-type="table-fn"}   Average mucoadhesion (%)[\#](#T000F2){ref-type="table-fn"}
  ----------- --------------- -------------------------------------------------------------- --------------------------------------------------------------------- ------------------------------------------------------------
  lM 1        65              61±1.88                                                        54.23±0.5                                                             89.56±0.4
  LM 2        62              66.78±1.3                                                      53.58±0.7                                                             89.23±1.7
  LM 3        74.2            75.2±0.66                                                      51.29±2.1                                                             88.7±2.2
  LM 4        75.1            69.45±0.71                                                     48.83±1.8                                                             86.38±1.2
  LM 5        63.89           69.3±1.54                                                      43.41±0.9                                                             85.92±0.8
  LM 6        61.74           72±0.94                                                        44.6±0.6                                                              84.81±1.5
  LM 7        70.16           73.6±0.45                                                      42.5±0.4                                                              85.13±1.8
  LM 8        64.04           74.4±0.81                                                      41.76±1.3                                                             83.8±2.2
  LM 9        71.3            74.2±0.64                                                      38.9±1.5                                                              82.61± 0.5

Values expressed as mean±SD, n=100

Values expressed as mean±SD, n=3
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